1. Home
  2. CTRI vs SRPT Comparison

CTRI vs SRPT Comparison

Compare CTRI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centuri Holdings Inc.

CTRI

Centuri Holdings Inc.

HOLD

Current Price

$33.45

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$20.77

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRI
SRPT
Founded
1909
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
CTRI
SRPT
Price
$33.45
$20.77
Analyst Decision
Hold
Hold
Analyst Count
5
29
Target Price
$29.88
$25.85
AVG Volume (30 Days)
1.1M
2.4M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
412.50
N/A
EPS
N/A
2.88
Revenue
$2,982,781,000.00
$2,198,237,000.00
Revenue This Year
$14.62
N/A
Revenue Next Year
$8.16
N/A
P/E Ratio
$166.16
N/A
Revenue Growth
13.10
15.58
52 Week Low
$18.59
$10.42
52 Week High
$42.99
$44.14

Technical Indicators

Market Signals
Indicator
CTRI
SRPT
Relative Strength Index (RSI) 45.81 46.98
Support Level $32.34 $16.09
Resistance Level $34.10 $23.31
Average True Range (ATR) 1.66 1.13
MACD 0.18 -0.04
Stochastic Oscillator 8.84 40.90

Price Performance

Historical Comparison
CTRI
SRPT

About CTRI Centuri Holdings Inc.

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: